In Wake of Restructuring, Beckman Cites Weak US Sales for Lackluster Clinical Dx Growth in Q2 | GenomeWeb

In addition to announcing a restructuring last week, Beckman Coulter reported modest gains in second quarter revenue but a significant drop in net income.

The firm reported revenue of $619 million, up 3.6 percent year over year, but its net earnings dropped 18.2 percent to $47.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.